(Q35552410)

8 August 2017

Radiation dose escalation in limited-stage small-cell lung cancer (English)

1 reference

8 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00715-6

18 March 2024

author name string

Panos Fidias

2

1 reference

8 August 2017

Marek Ancukiewicz

4

1 reference

8 August 2017

Kevin S. Roof

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529774

18 March 2024

Thomas J. Lynch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529774

18 March 2024

Noah C. Choi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529774

18 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0360301603007156?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0360-3016(03)00715-6

https://api.elsevier.com/content/article/PII:S0360301603007156?httpAccept=text/plain

18 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0360-3016(03)00715-6

International Journal of Radiation Oncology Biology Physics

18 March 2024

published in

1 reference

8 August 2017

57

1 reference

8 August 2017

3

1 reference

8 August 2017

701-708

1 reference

8 August 2017

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small-cell lung carcinoma: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900715-6

7 January 2021

Identifiers

DOI

1 reference

8 August 2017

1 reference